For Providers

Clinical Practice Support

Allergychoices provides expertise in sublingual immunotherapy, and can support you through initial dosing, escalation & ongoing patient management issues.

Working with your practice

We’ll support your practice in managing allergy patients following an elegantly simple protocol. The La Crosse Method™ Protocol, with its validated outcomes, has been proven safe and flexible enough to precisely treat a broad range of patients and conditions.

Our team is here to help you!

We offer a straightforward approach to ordering, managing previous orders, and tracking patients. We support your workflow with tools tailored to your practice goals.

Your support team

Expertise available to your practice:

  • Dosing questions

    Pharmacists available to answer dosing, escalation, or antigen-related questions

  • Complex cases

    Physician advisors to consult on clinical questions, especially for complex or atypical patient issues

  • Preparation

    Prescriptions prepared under a licensed pharmacy and credentialed staff

  • Quality assurance

    Quality assurance with detailed documentation, including lot number tracking

  • Dispensing

    Prescriptions delivered in a patient-friendly, metered dispenser to ensure precise dose administration

Questions about dosing, escalation, or a complex case? Talk to the team behind the protocol.

(866) 793-1680

Regulatory status of allergy drops

A small number of sublingual immunotherapy (SLIT) tablets are FDA-approved for specific allergens. Personalized allergy drops are compounded by a pharmacy for each patient and prescribed off-label — a long-standing, legitimate practice with decades of use, and SLIT is a first-line prescription approach in much of Europe. Compounded allergy drops are not FDA-approved, but they are created using FDA-approved allergenic extracts, the same as in allergy shots. Off-label does not mean unsafe or experimental.

U.S. allergenic extracts are licensed and labeled for injection and skin testing, not for the sublingual route, so prescribing them as sublingual drops is an off-label clinical decision made by the treating provider.

Next step

Offer allergy drops in your practice

Request a call and see how the La Crosse Method™ Protocol fits your workflow.